BusinessAXIM Biotechnologies Reports Second Quarter 2017 ResultsBy Nasdaq OMXAug 22, 2017, 1:01 PM UTC
BusinessAxim® Biotechnologies, Inc. Donates Flagship CanChew Gum to U.S. Pain Foundation to Help Chronic Pain SufferersBy Nasdaq OMXNov 22, 2016, 2:00 PM UTC
BusinessNew U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum ProductsBy Nasdaq OMXNov 16, 2016, 2:01 PM UTC
BusinessNew U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum ProductsBy Nasdaq OMXNov 16, 2016, 2:01 PM UTC
